TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees August 19, 1994
TCL Archive ACS Board To Consider Proposal For Implementing Cancer Response System Nationwide; Could End CIS June 7, 1985
